| Literature DB >> 28658560 |
Li Yin Drake1, Hirohito Kita1,2.
Abstract
Interleukin (IL)-33 is a key cytokine involved in type 2 immunity and allergic airway diseases. Abundantly expressed in lung epithelial cells, IL-33 plays critical roles in both innate and adaptive immune responses in mucosal organs. In innate immunity, IL-33 and group 2 innate lymphoid cells (ILC2s) provide an essential axis for rapid immune responses and tissue homeostasis. In adaptive immunity, IL-33 interacts with dendritic cells, Th2 cells, follicular T cells, and regulatory T cells, where IL-33 influences the development of chronic airway inflammation and tissue remodeling. The clinical findings that both the IL-33 and ILC2 levels are elevated in patients with allergic airway diseases suggest that IL-33 plays an important role in the pathogenesis of these diseases. IL-33 and ILC2 may also serve as biomarkers for disease classification and to monitor the progression of diseases. In this article, we reviewed the current knowledge of the biology of IL-33 and discussed the roles of the IL-33 in regulating airway immune responses and allergic airway diseases.Entities:
Keywords: IL-33; ILC2s; Th2 cells; asthma; rhinosinusitis; type 2 immunity
Mesh:
Substances:
Year: 2017 PMID: 28658560 PMCID: PMC5492954 DOI: 10.1111/imr.12552
Source DB: PubMed Journal: Immunol Rev ISSN: 0105-2896 Impact factor: 12.988